Quotables
"The horse is here to stay, the automobile is only a novelty - fad."
President of Michigan Savings Bank ; 1903
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7147864 | Methods for preventing photodamaged skin by administering selegiline or desmethylselegiline The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline. | 12/12/2006 |
| 6759053 | S(+) Desmethylselegiline and its use to treat ADHD The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions responsive... | 07/06/2004 |
| 6743824 | Method for preventing and treating peripheral neuropathy by administering selegiline The present invention is directed to methods for alleviating the symptoms associated with peripheral neuropathy. The neuropathy may be the result of a genetically inherited condition, systemic disease or exposure to a toxic agent. A reduction or elimination of sympt... | 06/01/2004 |
| 6709664 | Methods for treating photodamaged skin by administering selegiline or desmethylselegiline The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline. | 03/23/2004 |
| 6699495 | Methods for treating multiple sclerosis employing desmethylselegiline Methods and pharmaceutical compositions for using desmethylselegiline. In particular, the present invention provides novel compositions and methods for using desmethylselegiline for selegiline-responsive diseases and conditions. Diseases and conditions re... | 03/02/2004 |
| 6562364 | Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms The application is directed to the treatment of one or more symptoms associated with drug withdrawal by administering desmethylselegiline.... | 05/13/2003 |
| 6562365 | Methods employing R(-)-desmethylselegiline Methods and pharmaceutical compositions for using desmethylselegiline. In particular, the present invention provides novel compositions and methods for using desmethylselegiline for selegiline-responsive diseases and conditions. Diseases and conditions re... | 05/13/2003 |
| 6538036 | Method for preventing and treating peripheral neuropathy by administering selegiline The present invention is directed to methods for alleviating the symptoms associated with peripheral neuropathy. The neuropathy may be the result of a genetically inherited condition, systemic disease or exposure to a toxic agent. A reduction or eliminati... | 03/25/2003 |
| 6528082 | Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions The application is directed to the treatment of neoplastic diseases or conditions by administering R(-) desmethylselegiline, S(+) desmethylselegiline, or a combination of the two. Neoplastic diseases and conditions responsive to R(-) desmethylselegiline a... | 03/04/2003 |
| 6500868 | Method for preventing and treating peripheral neuropathy by administering selegiline A reduction or elimination of symptoms is obtained by administering the drug selegiline. The invention is also directed to a method for treating patients with cancer by administering a chemotherapeutic agent known to have a toxic affect on peripheral nerv... | 12/31/2002 |
| 6461619 | Method for treating wounds, burns and dermatological damage by administering selegiline or desmethylselegiline The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylse... | 10/08/2002 |
| 6455060 | S(+) desmethylselegiline and its use to treat immune system dysfunction The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions... | 09/24/2002 |
| 6420433 | S(+) desmethylselegiline and drug withdrawal The present invention provides novel compositions and methods for using the S-(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and condition... | 07/16/2002 |
| 6419948 | R(-)desmethylselegiline and its use in transdermal delivery compositions Methods and pharmaceutical compositions for using desmethylselegiline. In particular, the present invention provides novel compositions and methods for using desmethylselegiline for selegiline-responsive diseases and conditions. Diseases and conditions re... | 07/16/2002 |
| 6375979 | S(+) desmethylselegiline and its use in transdermal delivery compositions The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions... | 04/23/2002 |
| 6348208 | Methods and pharmaceutical compositions employing desmethylselegiline Methods and pharmaceutical compositions for using desmethylselegiline. In particular, the present invention provides novel compositions and methods for using desmethylselegiline for selegiline-responsive diseases and conditions. Diseases and conditions re... | 02/19/2002 |
| 6319954 | S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions The present invention provides novel compositions and methods for using the S-(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and condition... | 11/20/2001 |
| 6299901 | Methods and pharmaceutical compositions employing desmethylselegiline The application is directed to the treatment of one or more symptoms associated with drug withdrawal by administering desmethylselegiline.... | 10/09/2001 |
| 6239181 | Method for preventing and treating peripheral neurophathy by administering selegiline The present invention is directed to methods for alleviating the symptoms associated with peripheral neuropathy. The neuropathy may be the result of a genetically inherited condition, systemic disease or exposure to a toxic agent. A reduction or eliminati... | 05/29/2001 |
| 6210706 | S (+) Desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions... | 04/03/2001 |
| 6117912 | Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions The present invention is directed to improved methods for treating certain selegiline-responsive diseases or conditions and, more specifically, to methods in which selegiline is administered buccally or sublingually. Selegiline may be used ether as a free... | 09/12/2000 |
| 6033682 | S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions... | 03/07/2000 |
| 5242950 | Treatment of macular degeneration A method of treating macular degeneration is disclosed which comprises administering to a patient suffering from the disease a therapeutically effective amount of L-deprenyl or a pharmaceutically acceptable acid addition salt thereof for a period of time ... | 09/07/1993 |
